Evaluation of Chemotherapy Response with Serum Squamous Cell Carcinoma Antigen Level in Cervical Cancer Patients: A Prospective Cohort Study-Reference-Cited by-同舟云学术

Evaluation of Chemotherapy Response with Serum Squamous Cell Carcinoma Antigen Level in Cervical Cancer Patients: A Prospective Cohort Study

Published:2013-01-22 Issue:1 Volume:8 Page:e54969
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Yin Mingzhu,Hou Yan,Zhang Tao,Cui Changyi,Zhou Xiaohua,Sun Fengyu,Li Huiyan,Li Xia,Zheng Jian,Chen Xiuwei,Li Cong,Ning Xiaoming,Li Kang,Lou Ge

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference33 articles.

1. Modified type IV-V radical hysterectomy with systematic pelvic and aortic lymphadenectomy in the treatment of patients with stage III cervical carcinoma. Feasibility, technique, and clinical results;P Benedetti-Panici;Cancer,1996

2. Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix;T Iwasaka;Gynecol Oncol,1998

3. Use of neoadjuvant chemotherapy prior to radical hysterectomy in cervical cancer: monitoring tumor shrinkage and molecular profile on magnetic resonance and assessment of 3-year outcome;NM deSouza;Br J Cancer,2004

4. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced stage cervical cancer;M Yin;Int J Gynecol Cancer,2011

5. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survival;PB Panici;Cancer,1991

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unravelling the Complexities and Recent Advances in the Management of Atopic Dermatitis;Current Drug Therapy;2024-08-08

2. Are biomarkers expression and clinical-pathological factors predictive markers of the efficacy of neoadjuvant chemotherapy for locally advanced cervical cancer?;European Journal of Surgical Oncology;2024-06

3. eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma;Journal for ImmunoTherapy of Cancer;2022-03

4. Differences in Thymus and Activation-Regulated Chemokine and Squamous Cell Carcinoma Antigen 2 Levels in Food Protein-Induced Enterocolitis Syndrome and Atopic Dermatitis;International Archives of Allergy and Immunology;2022

5. Usefulness of Short-Term Imaging and Squamous Cell Carcinoma Antigen to Early Predict Response to Concurrent Chemoradiotherapy in Patients With Cervical Cancer;Cancer Control;2022-01